Skip to content

Clinical trials

Observational Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Country / region: United States Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20033
20041
20051
20062
20076
20089
20092
20105
20115
201215
20137
20147
20155
20163
20174
20183
20198
202011
20213
20227
20234
20242
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Recruiting17
Terminated16
Active, not recruiting9
Unknown status7
Enrolling by invitation3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)26
Novartis Pharmaceuticals7
Duke University5
Notal Vision Ltd.5
Oregon Health and Science University4
Sequenom, Inc.4
ORA, Inc.3
University of California, San Francisco3
University of Utah3
Astellas Pharma Global Development, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration131
Diabetic Retinopathy18
Geographic Atrophy16
Retinal Diseases11
Choroidal Neovascularization10
Glaucoma8
Retinal Vein Occlusion8
Retinal Degeneration7
Diabetes Mellitus6
Cataract5

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.